File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: QUERCETIN POTENTIALLY SUPPRESSES RENAL FIBROSIS IN PATIENTS WITH COVID-19 UNDER HYPOXIC STATE
| Title | QUERCETIN POTENTIALLY SUPPRESSES RENAL FIBROSIS IN PATIENTS WITH COVID-19 UNDER HYPOXIC STATE |
|---|---|
| Authors | |
| Issue Date | 20-Mar-2023 |
| Abstract | Renal fibrosis is a main outcome of acute kidney injury in COVID-19 survivors, which is emerging as a global public health concern. Lung damage in the COVID-19 patients leads to acute and chronic hypoxia, which results in inflammation, epithelial-mesenchymal transformation, and fibrosis in kidney. Quercetin is an abundant flavonoid in plant materials. Previous studies indicate that quercetin alleviates the decline of renal function, suppress epithelial to mesenchymal transformation in renal tubules, and reduce fibrosis. The study aimed to explore potential targets of quercetin on treating renal fibrosis in patients with COVID-19-induced hoxpia. |
| Persistent Identifier | http://hdl.handle.net/10722/338573 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Guo, Jianbo | - |
| dc.contributor.author | Chen, Haiyong | - |
| dc.contributor.author | Shao, Baoyi | - |
| dc.contributor.author | Wang, Yifan | - |
| dc.contributor.author | Wang, Jianan | - |
| dc.date.accessioned | 2024-03-11T10:29:54Z | - |
| dc.date.available | 2024-03-11T10:29:54Z | - |
| dc.date.issued | 2023-03-20 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/338573 | - |
| dc.description.abstract | <p>Renal fibrosis is a main outcome of acute kidney injury in COVID-19 survivors, which is emerging as a global public health concern. Lung damage in the COVID-19 patients leads to acute and chronic hypoxia, which results in inflammation, epithelial-mesenchymal transformation, and fibrosis in kidney. Quercetin is an abundant flavonoid in plant materials. Previous studies indicate that quercetin alleviates the decline of renal function, suppress epithelial to mesenchymal transformation in renal tubules, and reduce fibrosis. The study aimed to explore potential targets of quercetin on treating renal fibrosis in patients with COVID-19-induced hoxpia.<br></p> | - |
| dc.language | eng | - |
| dc.relation.ispartof | World Congress of Nephrology 2023 (30/03/2023-02/04/2023, Bangkok) | - |
| dc.title | QUERCETIN POTENTIALLY SUPPRESSES RENAL FIBROSIS IN PATIENTS WITH COVID-19 UNDER HYPOXIC STATE | - |
| dc.type | Conference_Paper | - |
| dc.identifier.doi | 10.1016/j.ekir.2023.02.981 | - |